← Back to Search

Behavioural Intervention

CSRS practice recommendation for Fainting

N/A
Recruiting
Led By Venkatesh Thiruganasambandamoorthy, CCFP-EM, MSc
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year from the index ed visit
Awards & highlights

Study Summary

This trial aims to introduce a new tool called the Canadian Syncope Risk Score (CSRS) to help emergency departments decide which patients with fainting episodes need further investigation or hospital admission. The goal is

Who is the study for?
This trial is for emergency department (ED) physicians and their delegates involved in the care of patients who faint, known as syncope. It aims to improve decision-making on whether these patients need further tests, monitoring, or hospital admission.Check my eligibility
What is being tested?
The study is testing the effectiveness of implementing Canadian Syncope Risk Score (CSRS)-based practice recommendations across multiple EDs. The goal is to see if using CSRS can reduce unnecessary hospitalizations and standardize patient discharge decisions.See study design
What are the potential side effects?
Since this trial involves a knowledge translation intervention rather than a medical treatment, there are no direct side effects like those associated with medications or procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year from the index ed visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year from the index ed visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of hospitalization
Secondary outcome measures
All-cause mortality
ED disposition time
Number of return ED visits
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CSRS practice recommendationExperimental Treatment1 Intervention
Knowledge translation of the Canadian Syncope Risk Score (CSRS) based practice recommendations

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
563 Previous Clinical Trials
2,773,317 Total Patients Enrolled
Venkatesh Thiruganasambandamoorthy, CCFP-EM, MScPrincipal InvestigatorOttawa Hospital Research Institute
2 Previous Clinical Trials
5,775 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

At how many distinct locations is this medical trial being administered?

"This clinical trial is operational at 8 sites, including St. Boniface Hospital in Winnipeg, University Health Network in Toronto, and Hôpital de L'Enfant-Jésus in Québec, along with additional locations across the country."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"According to the details provided on clinicaltrials.gov, this investigation is actively seeking volunteers. The trial was initially published on September 18th, 2023, and most recently revised on March 21st, 2024."

Answered by AI

What is the upper limit on the number of participants enrolled in this research endeavor?

"Indeed, details on clinicaltrials.gov affirm the ongoing recruitment status of this trial. The original posting date was 9/18/2023, with the most recent update noted as 3/21/2024. A total of 14400 individuals are being sought for participation across eight designated sites."

Answered by AI
~8914 spots leftby Jul 2025